BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,752,000 | +18.7% | 21,553 | +681.2% | 0.17% | +15.8% |
| Q4 2018 | $1,476,000 | +550.2% | 2,759 | -6.1% | 0.15% | +758.8% |
| Q3 2018 | $227,000 | -88.1% | 2,939 | -88.5% | 0.02% | -88.1% |
| Q2 2018 | $1,915,000 | +24.3% | 25,599 | +9.8% | 0.14% | +18.2% |
| Q1 2018 | $1,541,000 | -21.5% | 23,318 | -21.9% | 0.12% | -11.7% |
| Q4 2017 | $1,963,000 | -2.8% | 29,860 | -4.1% | 0.14% | -7.4% |
| Q3 2017 | $2,020,000 | +134.6% | 31,133 | +118.8% | 0.15% | +131.2% |
| Q2 2017 | $861,000 | -58.1% | 14,230 | -10.7% | 0.06% | -54.6% |
| Q1 2017 | $2,055,000 | +23.0% | 15,938 | +10.4% | 0.14% | +34.3% |
| Q4 2016 | $1,671,000 | +28.1% | 14,440 | -47.3% | 0.10% | +18.0% |
| Q3 2016 | $1,304,000 | -15.0% | 27,393 | -16.4% | 0.09% | +2.3% |
| Q2 2016 | $1,535,000 | -5.2% | 32,776 | -16.9% | 0.09% | -5.4% |
| Q1 2016 | $1,620,000 | – | 39,438 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |